The Management of Penile Fracture: a Review of the Literature with Special Consideration for Patients Undergoing Collagenase Clostridium Histolyticum Injection Therapy.


Journal

Current urology reports
ISSN: 1534-6285
Titre abrégé: Curr Urol Rep
Pays: United States
ID NLM: 100900943

Informations de publication

Date de publication:
20 Jan 2021
Historique:
accepted: 23 11 2020
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 24 4 2021
Statut: epublish

Résumé

To review the current literature on acute management of traumatic penile fracture, with a specific discussion of those injuries following collagenase clostridium histolyticum (CCH) injections for the treatment of Peyronie's disease. The immediate repair of traumatic penile fracture injury is associated with significantly better prognosis for long-term sexual health. Corporal disruption following CCH administration has several distinct features, and the trend is to manage these patients conservatively in the absence of urethral injury. Traumatic penile fracture repair continues to have excellent results when performed immediately following injury. The post-CCH treatment setting portends increased difficulty during surgical management and can be successfully managed in most cases by conservative measures.

Identifiants

pubmed: 33471204
doi: 10.1007/s11934-020-01025-7
pii: 10.1007/s11934-020-01025-7
doi:

Substances chimiques

Urological Agents 0
Microbial Collagenase EC 3.4.24.3

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

13

Auteurs

William M Hughes (WM)

Department of Urology, Tulane University School of Medicine, 1430 Tulane Ave, 8642, New Orleans, LA, 70112, USA.

Caleb Natale (C)

Department of Urology, Tulane University School of Medicine, 1430 Tulane Ave, 8642, New Orleans, LA, 70112, USA.

Wayne J G Hellstrom (WJG)

Department of Urology, Tulane University School of Medicine, 1430 Tulane Ave, 8642, New Orleans, LA, 70112, USA. whellst@tulane.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH